蛋白质纳米疫苗共发射刺针激动剂,增强树突细胞活化和抗瘤免疫力
Peidong Yang1, Xiaoming Hu2,3, Weibin Lian1
1Department of Breast Surgery, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, China.
ACS applied materials & interfaces
|January 13, 2026
概括
这项研究介绍了一种新的癌症纳米疫苗策略,使用蛋白质交叉链接和STING激活. 这种方法简化了配方,并通过稳定抗原和刺激免疫细胞来增强抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 癌症纳米疫苗显示出潜力,但在抗原输送,免疫激活和配方方面面临挑战.
- 有效的输送和免疫刺激对于有效的癌症免疫疗法至关重要.
研究的目的:
- 开发一种自我辅助的癌症纳米疫苗的通用化策略.
- 将抗原稳定,淋巴结传递和先天免疫激活整合到一个纳米系统中.
- 在临床前癌症模型中评估基于STING激动剂的纳米疫苗的疗效.
主要方法:
- 蛋白质交叉链接被用来创建纳米疫苗,其中包括STING激动剂MSA-2.
- 纳米疫苗配方 (M2-OVA-NP) 进行了测试,以测试其激活树突细胞中的cGAS-STING通路的能力.
- 在体内研究评估了纳米疫苗在淋巴结中的积累,T细胞反应和小鼠的瘤生长抑制.
主要成果:
- M2-OVA-NP纳米疫苗激活了cGAS-STING通路,促进了树突细胞的成熟,并增强了CD8+T细胞的原始化.
- 在体内,纳米疫苗有效地到达了排水淋巴结,并诱导了显著的瘤透T细胞.
- 在接受治疗的小鼠中观察到显著的瘤生长抑制和改善的生存率.
结论:
- 开发的战略提供了一个简单和模块化的方法来构建自我辅助的蛋白质纳米疫苗.
- 将抗原输送与STING介导的先天性免疫激活相结合,为癌症免疫疗法提供了一个有前途的途径.
- 这种纳米疫苗设计克服了癌症纳米疫苗开发的关键挑战,为实际应用铺平了道路.
更多相关视频
10:06Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
Published on: September 2, 2022
2.2K
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
2.2K
相关概念视频
01:30Cancer Vaccines
946
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946
01:51Vaccinations
51.2K
Overview
51.2K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:29Immune Response Against Viral Pathogens
1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K